Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis

Bograd, Alexandra; Villiger, Peter M.; Munk, Marion R.; Bolt, Isabel; Tappeiner, Christoph (2022). Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis (In Press). Ocular immunology and inflammation, pp. 1-4. Taylor & Francis 10.1080/09273948.2021.2024580

[img] Text
tocilizumab_und_aflibercept_arn.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Bograd, Alexandra Emma Olga; Munk, Marion; Bolt, Isabel Bettina and Tappeiner, Christoph

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1744-5078

Publisher:

Taylor & Francis

Language:

English

Submitter:

Marion Munk

Date Deposited:

08 Feb 2022 14:41

Last Modified:

09 Feb 2022 00:14

Publisher DOI:

10.1080/09273948.2021.2024580

PubMed ID:

35060816

BORIS DOI:

10.48350/164727

URI:

https://boris.unibe.ch/id/eprint/164727

Actions (login required)

Edit item Edit item
Provide Feedback